Elyxium Wealth’s Elevance Health ELV Stock Holding History

Elyxium Wealth’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-166	Closed	-$58.2K	–	482
2025 Q4	$58.2K	Buy	+166	New	+$56.1K	0.02%	323
2025 Q3	–	Sell	-609	Closed	-$237K	–	170
2025 Q2	$237K	Buy	+609	New	+$245K	0.09%	149

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Elyxium Wealth's ELV Position: Q1 2026 in Review

Elyxium Wealth sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 166 shares — an estimated $58.2K sold.

Elyxium Wealth first reported a position in ELV in Q2 2025 and held it in 2 quarters. The position peaked at $237K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Elyxium Wealth reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Elyxium Wealth sold 166 Elevance Health shares in Q1 2026, an estimated $58.2K.
Elyxium Wealth first reported a position in Elevance Health in Q2 2025 and held it in 2 quarters.
Elyxium Wealth's Elevance Health position peaked at $237K in Q2 2025.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.